ELEV
Elevation Oncology, Inc. - Common stock (ELEV)
$38
About Elevation Oncology, Inc. - Common stock (ELEV)
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.
Details
Daily high
$0.38
Daily low
$0.37
Price at open
$0.38
52 Week High
$3.09
52 Week Low
$0.22
Market cap
22.5M
Dividend yield
0.00%
Volume
566,390
Avg. volume
988,374
P/E ratio
-.47
Elevation Oncology, Inc. - Common stock News
Details
Daily high
$0.38
Daily low
$0.37
Price at open
$0.38
52 Week High
$3.09
52 Week Low
$0.22
Market cap
22.5M
Dividend yield
0.00%
Volume
566,390
Avg. volume
988,374
P/E ratio
-.47